METHYCOBAL

This brand name is authorized in Cyprus, Hong Kong, Japan, Singapore

Active ingredients

The drug METHYCOBAL contains one active pharmaceutical ingredient (API):

1 Mecobalamin UNII BR1SN1JS2W - METHYLCOBALAMIN

Methylcobalamin is a cobalamin, a form of vitamin B12. Mecobalamin is a kind of endogenous coenzyme B12. Mecobalamin plays an important role in transmethylation as a coenzyme of methionine synthetase in the synthesis of methionine from homocysteine. Mecobalamin promotes axonal transport and axonal regeneration. Mecobalamin promotes myelination (phospholipid synthesis). Methylcobalamin is used in the treatment of peripheral neuropathy, diabetic neuropathy, and as a preliminary treatment for amyotrophic lateral sclerosis. Read about Mecobalamin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
METHYCOBAL Solution for injection	Υπουργείο Υγείας (CY)	MPI, EU: SmPC
METHYCOBAL Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03BA05	Mecobalamin	B Blood and blood forming organs → B03 Antianemic preparations → B03B Vitamin B12 and folic acid → B03BA Vitamin B12 (cyanocobalamin and analogues)
Discover more medicines within B03BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 30872, 35777, 64652
Country: JP	医薬品医療機器総合機構	Identifier(s): 3136004C1038, 3136004F1050, 3136004F2138, 3136403A1140
Country: SG	Health Sciences Authority	Identifier(s): 06291P, 06349P